Melissa Davis

Inside Baseball at HCA

 

Over the years, HCA (HCA) insiders have shown a real knack for well-timed stock sales.

Their efforts haven't always drawn the kind of spotlight now beating down on the Nashville, Tenn., hospital chain. But then, the insiders weren't often selling just ahead of a profit warning that would send the stock into a tailspin. Nor were they usually selling alongside a member of the founding family and a high-ranking politician, Sen. Bill Frist.

The government is now investigating the well-timed sales of HCA stock by the Tennessee Republican. Frist denies wrongdoing, saying the sales were part of an effort to eliminate even the appearance of a potential conflict of interest.

But Frist's critics point out that the Senate majority leader plays a major role in shaping health-care policies that could impact the giant for-profit hospital chain that his family built. And even some who called for Frist to sell his HCA stock question why he finally decided to do so now.

"If there is a conflict now, why wasn't there a conflict when he came into office or when he became Senate majority leader?" asks Bill Allison, a spokesman for the nonpartisan government ethics watchdog group known as the Center for Public Integrity. "And with his family still involved with HCA, I don't know that selling the stock even ends the conflict of interest. ... The timing of this doesn't quite make sense."

Or, Allison goes on to suggest, maybe it does. After all, he notes, Frist decided to sell his stock at the same time that another powerful Republican senator -- Finance Chairman Chuck Grassley of Iowa -- was crafting a bill that could bring sweeping changes to the Medicare reimbursement system. Under that proposal, recommended by the Centers for Medicare and Medicaid Services (CMS), Medicare would start paying hospitals based on their costs for treating patients instead of the amount the hospitals actually charge.

TheStreet Premium Services

Jim Cramer
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
Dow Jones S&P 500 NASDAQ 10-Year Note
12,419.86 1,313.32 2,837.36 16.25
Oil *
103.00
DOWN
160.83
DOWN
19.10
DOWN
33.63
DOWN
1.06
10 Yr
1.62%
SPDR Gold
151.91
-1.28%
-1.43%
-1.17%
-6.12%
Data delayed 20 minutes

Top Stories and Tools

Articles From

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy.
Podcasts

Connect with TheStreet